text stringlengths 0 5.79k |
|---|
*[[Astroblastoma]], MN1-altered. |
=Diffuse growing astrocytomas= |
*[[Astrocytoma, IDH-mutant]]. |
*[[Glioblastoma]], IDH wildtype. |
*[[Diffuse midline glioma, H3 K27-altered]]. |
*[[Diffuse hemispheric glioma, H3 G34-mutant]]. |
*[[Diffuse astrocytoma, MYB- or MYBL-altered]]. |
*Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype. |
*Angiocentric glioma. |
*Diffuse low-grade glioma, MAPK pathway-altered. |
=Circumscribed astrocytomas= |
*[[Pilocytic astrocytoma]]. |
*[[High-grade astrocytoma with piloid features]]. |
*[[Pleomorphic xanthroastrocytoma]]. |
*[[Subependymal giant cell astrocytoma]]. |
*[[Chordoid glioma]]. |
*[[Astroblastoma]], MN1-altered. |
=Common Astrocytomas= |
==Pilocytic astrocytoma== |
* Benign, cystic, infratentorial. |
* Classic childhood tumor, surgically resectable. |
* Circumscribed astrocytic glioma |
* Variant: [[Pilomyxoid astrocytoma]] |
{{Main|Pilocytic astrocytoma}} |
==Astrocytoma, IDH mutant== |
* Astrocytoma, IDH mutant are less common than glioblastoma. |
* Grade 2-4 depends on histological and molecular criteria: |
{{Main|Astrocytoma, IDH-mutant}} |
=== Astrocytoma, IDH mutant grade 2=== |
* Formerly designated as Diffuse astrocytoma Grade II. |
* Typically seen in adults. |
* Usually shows progression to astrocytoma IDH mutant, grade 4. |
===Astrocytoma, IDH mutant grade 3=== |
* Formerly designated Anaplastic astrocytoma Grade III. |
* Typically seen in adults. |
* Increased cellularity, cell atypia and mitotic activity. |
* Lacks endothelial proliferations and necrosis of glioblastoma. |
===Astrocytoma, IDH mutant grade 4=== |
* Formerly called Glioblastoma, IDH mutant. |
* Endothelial proliferations and necrosis indistinguishable from glioblastoma. |
* Homozygous CDKN2A deletion qualifies grade 2 and grade 3 astrocytomas as grade 4 tumor. |
==Glioblastoma== |
* Most common malignant brain tumor peaking around 65 years. |
* Prognosis very poor. |
* Variant: [[Giant cell glioblastoma]] |
* Variant: [[Gliosarcoma]] |
{{Main|Glioblastoma}} |
=Uncommon Astrocytomas= |
==Diffuse astrocytoma, MYB- or MYBL-altered== |
* Pediatric-type diffuse low-grade glioma. |
* Associated with epileptic seizures. |
* Excellent prognosis. |
{{Main|Diffuse astrocytoma, MYB- or MYBL-altered}} |
==Subependymal giant cell astrocytoma== |
* Intraventricular benign tumor of adolescents. |
* Associated with [[Tuberous sclerosis]]. |
{{Main|Subependymal giant cell astrocytoma}} |
==Pleomorphic xanthroastrocytoma (PXA)== |
* Kids & young adults usually with good prognosis. |
* Large lipidized cells mimicking a malignant tumor |
{{Main|Pleomorphic xanthoastrocytoma}} |
==Diffuse midline glioma, H3 K27-altered== |
* High-grade astrocytic neoplasm associated with midline structures (thalamus, brain stem, spinal cord). |
* Mostly in children and adolescents. |
* Includes diffuse intrinsic pontine gliomas (DPIG). |
{{Main|Diffuse midline glioma, H3 K27-altered}} |
==Diffuse hemispheric glioma, H3 G34-mutant== |
* Infiltrative hemispheric glioma of young adults. |
* Glioblastoma-like appearance (CNS WHO grade 4 tumor). |
* Newly defined entity in WHO 2021 classification. |
* H3F3A missense mutation G34R or G34V. |
{{Main|Diffuse hemispheric glioma, H3 G34-mutant}} |
==High-grade astrocytoma with piloid features== |
* Frequent in posterior fossa (75%). |
* 1-3% of all brain tumors. |
* Histology may resemble Glionblastoma or Pleomorphic xanthoastrocytoma. |
* Tumor is enriched for piloid cell processes. |
* ATRX nuclear loss is frequent. |
* Usu. MAPK-pathway alterations + CDKN2A homozygous deletion. |
* Distinct methylation profile. |
{{Main|High-grade astrocytoma with piloid features}} |
==Gliomatosis cerebri== |
* Depreceated entity. |
* Was used for extensively diffusely growing astrocytic neoplasms. |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.